The most experienced and trusted provider of Biosafety solutions, the WIRB-Copernicus Group® (WCG) has evaluated over 150 human gene transfer protocols to date – more than any organization outside of the Food and Drug Administration (FDA) and the National Institute of Health (NIH). We also maintain a global presence, operating Institutional Biosafety Committees (IBCs) in the United States and Canada, as well as in eight countries in Africa, South America, Central America, the Caribbean, and Europe.

The demands for biologic safety are – and will continue to be – dynamic. Through their trusted partnership with WCG, our clients achieve the safe and successful management of research involving rDNA and other potentially hazardous biological vectors.

Our Services Include:

  • IBC Review Services
  • Biosafety Management
  • IBC and Biosafety Program Assessments
  • Biosafety Training (select agents, blood borne pathogens, IATA/DOT shipping, and customized topics)
  • Transitional Support (internal IBC administration to external IBC administration)
  • Accreditation Support (for the use of newly-approved biologic and gene therapy products)
  • Clinical Trial Protocol Development for Recombinant Materials (subject to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acids)
Print Friendly